On April 29, Diagnostic Kit for COVID-19 Antigen Test (Colloidal Gold)” developed by KHB was approved by NMPA (Registration Certificate No.: GXZZ 20223400568) and officially launched on the market. As a local enterprise in Shanghai, KHB actively responds to the national self-testing policy and helps universal screening, thus contributes to the fight against the COVID-19 epidemic.

    KHB’s Diagnostic Kit for COVID-19 Antigen Test (Colloidal Gold)” has the following features:

    Results obtained fast

    KHB’s Diagnostic Kit for COVID-19 Antigen Test (Colloidal Gold)” delivers results in 15 minutes, compared with nucleic acid, which requires several hours of waiting.

    Easy detection

    Penetrate 1.5cm into the nasal cavity for sampling, which greatly reduces the discomfort and improves the success rate of sampling.

    Wide applicability

    Can be used in hospitals or at home, avoiding the tedium of waiting in line at hospitals and the risk of exposure to crowds.

    As one of the few veteran in vitro diagnostic companies with 40 years of history in China, in addition to the widely acclaimed biochemical immunology products, KHB has more than 20 years of experience in the development and production of POCT colloidal gold assays, of which colloidal gold HIV products makes the company become the first domestic manufacturer entering the WHO’s procurement catalog.

    As early as May 2021, KHB has completed the EU CE certification for Diagnostic Kit for COVID-19 Antigen Test (Colloidal Gold)” through TGS (TechnoGenetics), its holding subsidiary in Italy, , and entered the procurement white list of CCCMHPIE, so that the products can be widely used in most regions of the world, which played an important role in local government's epidemic prevention and control.

KHB Sales Contact